Search Within

Nancy Bouvier

  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (11)
  2. Meeting Abstract (9)
  3. Research Letter (1)
Groups
  1. Department of Medicine (21)
  2. GSK Faculty (21)
  3. Genitourinary Oncology Service (21)
  4. Solid Tumor Oncology Division (21)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (20)
  6. Department of Pathology and Laboratory Medicine (20)

More Groups

People
  1. Michael Berger (18)
  2. David Solit (15)
  3. Nikolaus Schultz (9)
  4. Barry Taylor (8)
  5. Ahmet Zehir (7)
  6. David Hyman (7)

More People

Years
  1. 2023 (1)
  2. 2021 (2)
  3. 2020 (2)
  4. 2019 (3)
  5. 2018 (2)
  6. 2017 (5)

More Years

Publications
  1. Journal of Clinical Oncology (6)
  2. Cancer Discovery (2)
  3. Cancer Research (2)
  4. Nature (2)
  5. Annals of Oncology (1)
  6. BJU International (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (7)
  2. American Association for Cancer Research (5)
  3. Nature Publishing Group (3)
  4. Wiley Blackwell (2)
  5. Elsevier Science, Inc. (1)
  6. John Wiley & Sons (1)

More Publishers

Results (21)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Correlation of benefit from immune checkpoint inhibitors with next gen sequencing (NGS) profiles in esophagogastric cancer (EGC) patients
    Meeting Abstract

    Ku, G. Y.; Sanchez-Vega, F.; Chatila, W.; Margolis, M.; Fein, C.; Ilson, D. H.; Hechtman, J. F.; Tuvy, Y.; Bouvier, N.; Kundra, R.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • DNA damage response and repair gene alterations are associated with improved survival in patients with platinum-treated advanced urothelial carcinoma
    Journal Article

    Teo, M. Y.; Bambury, R. M.; Zabor, E. C.; Jordan, E.; Al-Ahmadie, H.; Boyd, M. E.; Bouvier, N.; Mullane, S. A.; Cha, E. K.; Roper, N.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • AKT inhibition in solid tumors with AKT1 mutations
    Journal Article

    Hyman, D. M.; Smyth, L. M.; Donoghue, M. T. A.; Westin, S. N.; Bedard, P. L.; Dean, E. J.; Bando, H.; El-Khoueiry, A. B.; Pérez-Fidalgo, J. A.; Mita, A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Next-generation sequencing of urine specimens: A novel platform for genomic analysis in patients with non–muscle-invasive urothelial carcinoma treated with bacille Calmette-Guérin
    Journal Article

    Scott, S. N.; Ostrovnaya, I.; Lin, C. M.; Bouvier, N.; Bochner, B. H.; Iyer, G.; Solit, D.; Berger, M. F.; Lin, O.
    Cancer Cytopathology (2017)

    Fulltext@MSK | Save
  • Genomic biomarkers of a randomized trial comparing first-line everolimus and sunitinib in patients with metastatic renal cell carcinoma
    Journal Article

    Hsieh, J. J.; Chen, D.; Wang, P. I.; Marker, M.; Redzematovic, A.; Chen, Y. B.; Selcuklu, S. D.; Weinhold, N.; Bouvier, N.; Huberman, K. H.; more...
    European Urology (2017)

    Fulltext@MSK | Save
  • Emergence of RTK/RAS/PI3K pathway alterations in trastuzumab-refractory HER2-positive esophagogastric (EG) tumors
    Meeting Abstract

    Janjigian, Y. Y.; Sanchez-Vega, F.; Tuvy, Y.; Bouvier, N.; Riches, J. C.; Margolis, M.; Millang, B. M.; Scott, S. N.; Kundra, R.; Castel, P.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Clinical next generation sequencing (NGS) of esophagogastric (EG) adenocarcinomas identifies distinct molecular signatures of response to HER2 inhibition, first-line 5FU/platinum and PD1/CTLA4 blockade
    Meeting Abstract

    Janjigian, Y. Y.; Sanchez-Vega, F.; Jonsson, P.; Tuvy, Y.; Bouvier, N.; Riches, J.; Kundra, R.; Ku, G.; Hechtman, J. F.; Kelsen, D.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Genomic alterations indicative of a luminal A subtype associate with clinical benefit to buparlisib and letrozole in endocrine-resistant ER+/HER2- metastatic breast cancer
    Meeting Abstract

    Balko, J. M.; Hicks, M.; Berger, M. F.; Solit, D. B.; Bouvier, N.; Sanders, M. E.; Estrada, M. V.; Won, H.; Cantley, L. C.; Mayer, I. A.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Identification of efficacy biomarkers in a large metastatic renal cell carcinoma (mRCC) cohort through next-generation sequencing (NGS): Results from RECORD-3
    Meeting Abstract

    Hsieh, J. J.; Chen, D.; Wang, P. I.; Chen, Y. B.; Redzematovic, A.; Marker, M.; Patel, P.; Chevinsky, M.; Bhanot, U.; Pinciroli, P.; more...
    BJU International (2015)

    Fulltext@MSK | Save
  • Identification of efficacy biomarkers in a large metastatic renal cell carcinoma (mRCC) cohort through next generation sequencing (NGS): Results from RECORD-3
    Meeting Abstract

    Hsieh, J.; Chen, D.; Wang, P.; Chen, Y. B.; Redzematovic, A.; Marker, M.; Patel, P.; Chevinsky, M.; Bhanot, U.; Pinciroli, P.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save